Quidel Expects Q4 Revenues Above Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Quidel today said that it expects to report fourth-quarter revenues of $53 million to $54 million.

That figure is well above Wall Street's consensus estimate for revenues of $43.8 million.

"We saw a sudden and early onset to this year's influenza season," Quidel President and CEO Douglas Bryant said in a statement. "I am pleased, however, with how well we were able to respond to the increased and rapid demand for our flu tests."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.